Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline(updated version)
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline（updated version）作者机构：Center for Evidence-Based and Translational MedicineZhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Respiratory DiseasesChina-Japan Friendship HospitalBeijing 100029China Department of Pulmonary and Critical Care MedicineChina-Japan Friendship HospitalBeijing 10029China Leishenshan Hospital in WuhanWuhan 430200China Department of Critical Care MedicineZhongnan Hospital of Wuhan UniversityWuhan 430071China Institutes of Evidence-based Medicine and Knowledge TranslationHenan UniversityKaifeng 475000HenanChina Department of Medical ImagingGuizhou Provincial People’s HospitalGuiyang 550002China Departments of OrthopedicsZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Hepatobiliary SurgeryZhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for GeriatricsWest China Hospital of Sichuan UniversityChengdu 610041China Department of GeriatricsWest China Hospital of Sichuan UniversityChengdu 610041China Department of RadiologyZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Clinical LaboratoryPeking Union Medical College Hospital(PUMCH)Peking Union Medical CollegeChinese Academy of Medical Sciences(CAMS)Beijing 100730China Center for Primary Health Care ResearchLund University and Region Skåne25002 MalmöSweden Emergency CenterZhongnan Hospital of Wuhan UniversityWuhan 403371China Department of AllergologyZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Radiation and Medical OncologyZhongnan Hospital of Wuhan UniversityWuhan 43071China Department of Critical Care MedicineRenmin Hospital of Wuhan UniversityWuhan 430060China Department of Emergency Medicine and Chest Pain CenterQilu Hospital of Shandong UniversityJinan 250002China Department of Respiratory and Critical Care MedicineSuizhou Central HospitalHubei University of MedicineSuizhou 441300HubeiChina Department of Clinic PharmacySecond People’s Hospital of Huaihua CityHuaihua 418000HunanChina Department of Intensive Care UnitThe Second Affiliated Hospital of Anhui Medical UniversityHefei 230601China Department of Internal MedicineZhengzhou University HospitalZhengzhou 450001China Department of Respiratory and Critical Care MedicineHenan Provincial People’s HospitalZhengzhou 450003China Department of Infectious DiseasesChildren’s Hospital of Fudan UniversityShanghai 201102China Department of Infectious DiseaseWest China Second HospitalSichuan UniversityChengdu 610041China Department of CardiologyThe First Affiliated Hospital of Henan University of Chinese MedicineZhengzhou 450000China Department of CardiologyYichang NO.1 HospitalRenmin Hospital of China Three Gorges UniversityYichang 443000HubeiChina Department of PediatricsZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of PharmacyTongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430030China Department of PharmacyShandong Provincial HospitalShandong First Medical University&Shandong Academy of Medical SciencesJinan 250021China Laboratory of Integrated Acupuncture and DrugsNanjing University of Chinese MedicineNanjing 210023China Department of Periodical PressWest China HospitalSichuan UniversityChengdu 610041China Department of Clinical LaboratoryYantai Yuhuangding HospitalQingdao UniversityYantai 264000ShandongChina Department of RadiologyTaihe HospitalHubei University of MedicineShiyan 442000HubeiChina School of NursingPeking UniversityBeijing 100191China Department of Respiratory and Critical Care MedicineKaifeng Central HospitalKaifeng 475000HenanChina Department of EmergencyBeijing Electric Power HospitalBeijing 100073China ICU CenterThe Second Xiangya HospitalCentral South UniversityChangsha 410008China Department of UrologyZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of HaematologyZhongnan HospitalWuhan UniversityWuhan 430071China College of Nursing and HealthHenan Medical SchoolHenan UniversityKaifeng 475000HenanChina School of NursingShanxi Medical UniversityTaiyuan 030001China Department of Diagnostic RadiologyBeijing You’an HospitalCapital Medical UniversityBeijing 100069China Department of Respiratory MedicineZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Health Research MethodsEvidenceand ImpactMcMaster UniversityHamiltonOntario L8S 4L8Canada
出 版 物：《Military Medical Research》 (军事医学研究（英文版）)
年 卷 期：2020年第7卷第3期
页 面：249-282页
核心收录：
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金：supported(in part)by the National Key Research and Development Program of China(2020YFC0845500) the Special Project for Emergency of Hubei Province(2020FCA008) the First Level Funding of the Second Medical Leading Talent Project in Hubei Province
主 题：COVID-19 SARS-CoV-2 Recommendation Chemoprophylaxis Diagnosis Treatment Discharge management Traditional Chinese medicine guideline
摘 要：The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the cause of a rapidly spreading illness,coronavirus disease 2019(COVID-19),affecting more than seventeen million people around the *** and treatment guidelines for clinicians caring for patients are *** the early stage,we have issuedA rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version);now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based *** formed a working group of clinical experts and *** steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas:chemoprophylaxis,diagnosis,treatments,and discharge *** searched the literature for direct evidence on the management of COVID-19,and assessed its certainty generated recommendations using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)*** were either strong or weak,or in the form of ungraded consensus-based ***,we issued 34 *** them,6 were strong recommendations for,14 were weak recommendations for,3 were weak recommendations against and 11 were ungraded consensus-based *** covered topics of chemoprophylaxis(including agents and Traditional Chinese Medicine(TCM)agents),diagnosis(including clinical manifestations,reverse transcription-polymerase chain reaction(RT-PCR),respiratory tract specimens,IgM and IgG antibody tests,chest computed tomography,chest X-ray,and CT features of asymptomatic infections),treatments(including lopinavirritonavir,umifenovir,favipiravir,interferon,remdesivir,combination of antiviral drugs,hydroxychloroquine/chloroquine,interleukin-6 inhibitors,interleukin-1 inhibitors,glucocorticoid,qingfei paidu decoction,lianhua qingwen granules/capsules,convalescent plasma,lung
维普期刊数据库
同方期刊数据库